Publication: 3262

Publication: 3262

ALTERNATE: Neoadjuvant endocrine treatment (NET) approaches for clinical stage II or III Estrogen Receptor positive HER2 negative breast cancer (ER+ HER2- BC) in postmenopausal (PM) women: Alliance A011106

DOI

URL

Google Scholar

Citation:: J Clin Oncol vol 38 (15_suppl) 504

Meeting Instance:: ASCO 2020
Year:: 2020
Type:: Abstract
Sub type:: Oral
Funding:: NCTN
Endpoint:: Primary
Analysis:: Primary
Data Sharing:: No-Data-Sharing
Status:: Presented/Published
Citation Status:: epub

Note:

Methodological:: No
Biospecimen:: Yes
SDC:: No

Parents:: None
Children:: 3910

Program:: OGC
Primary Committee:: Breast
Sec. Committees:

Pharmas:: AstraZeneca, Genentech
Grants:: U10CA180821, U10CA180882, U24CA196171, U10CA180868 (NRG); Alliance Foundation

Corr. Author:
Authors:: Cynthia X. Ma Vera Suman A. Marilyn Leitch Souzan Sanati Kiran Vij Gary W. Unzeitig Jeremy Hoog Mark Watson Olwen Hahn Joseph Guenther Abigail Caudle J. Michael Guenther Travis Dockter Larissa Korde Anna Weiss Kelly Hunt Clifford Hudis Eric P. Winer Ann Partridge Lisa Carey Matthew J. Ellis

Networks:: KY015, LAPS-CT018, LAPS-IL057, LAPS-MA036, LAPS-MO011, LAPS-NC007, LAPS-NY016, LAPS-TX011, LAPS-TX035, NY167, TX041, TX190

Study: Alliance-A011106
Multiple Studies, or Legacy Studies in Alliance Study:
Phases:: 3

Keywords: